Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosisFerdinando Nicoletti, A. Reggio, Francesco Patti et al.|Journal of Neuroimmunology|1996Cited by 114
Interleukin-13 prevents autoimmune diabetes in NOD mice.Paola Zaccone, Ferdinando Nicoletti, Jenny M. Phillips et al.|Diabetes|1999Cited by 86
Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-γ-dependent mechanismFerdinando Nicoletti, Pier Luigi Meroni, Roberto Di Marco et al.|Hepatology|2000Cited by 81
Blood levels of transforming growth factor-beta 1 (TGF-β1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-β1b)Ferdinando Nicoletti, A. Reggio, Roberto Di Marco et al.|Clinical & Experimental Immunology|1998Cited by 80
CIRCULATING SERUM LEVELS OF IL-1ra IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS ARE NORMAL DURING REMISSION PHASES BUT SIGNIFICANTLY INCREASED EITHER DURING EXACERBATIONS OR IN RESPONSE TO IFN-β TREATMENTFerdinando Nicoletti, A. Reggio, Francesco Patti et al.|Cytokine|1996Cited by 77